Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment
- PMID: 9719344
- DOI: 10.1016/s0163-7258(98)00008-4
Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment
Abstract
Severe falciparum malaria is one of the most lethal parasitic infections in the world and is responsible for more than one million deaths in African children per year. Changes to management over the last 40 years have not improved survival. A reduction in the mortality and morbidity may only come about by a better understanding of the pathophysiological processes that are responsible for severe disease and that determine the outcome before antimalarials have had time to work. This review discusses potential adjunctive therapies for severe malaria that are under development following such detailed clinical and pathophysiological studies.
Similar articles
-
Severe malaria: what's new on the pathogenesis front?Int J Parasitol. 2017 Feb;47(2-3):145-152. doi: 10.1016/j.ijpara.2016.08.002. Epub 2016 Sep 23. Int J Parasitol. 2017. PMID: 27670365 Free PMC article. Review.
-
Adjunctive therapy for cerebral malaria and other severe forms of Plasmodium falciparum malaria.Expert Rev Anti Infect Ther. 2010 Sep;8(9):997-1008. doi: 10.1586/eri.10.90. Expert Rev Anti Infect Ther. 2010. PMID: 20818944 Free PMC article. Review.
-
Children with retinopathy-negative cerebral malaria: a pathophysiologic puzzle.Pediatr Infect Dis J. 2011 Nov;30(11):953-6. doi: 10.1097/INF.0b013e3182271c69. Pediatr Infect Dis J. 2011. PMID: 21694660 Free PMC article.
-
Immunopathogenesis of falciparum malaria: implications for adjunctive therapy in the management of severe and cerebral malaria.Expert Rev Anti Infect Ther. 2011 Sep;9(9):803-19. doi: 10.1586/eri.11.96. Expert Rev Anti Infect Ther. 2011. PMID: 21905788 Review.
-
Persistent cognitive impairment after cerebral malaria: models, mechanisms and adjunctive therapies.Expert Rev Anti Infect Ther. 2010 Nov;8(11):1209-12. doi: 10.1586/eri.10.117. Expert Rev Anti Infect Ther. 2010. PMID: 21073283 No abstract available.
Cited by
-
3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum.BMC Struct Biol. 2016 Aug 17;16:12. doi: 10.1186/s12900-016-0063-7. BMC Struct Biol. 2016. PMID: 27534744 Free PMC article.
-
Exchange transfusion in complicated pediatric malaria: A critical appraisal.Indian J Crit Care Med. 2015 Apr;19(4):214-9. doi: 10.4103/0972-5229.154554. Indian J Crit Care Med. 2015. PMID: 25878429 Free PMC article. Review.
-
Modulation of cerebral malaria by curcumin as an adjunctive therapy.Braz J Infect Dis. 2013 Sep-Oct;17(5):579-91. doi: 10.1016/j.bjid.2013.03.004. Epub 2013 Jul 29. Braz J Infect Dis. 2013. PMID: 23906771 Free PMC article. Review.
-
Pharmacokinetics and clinical effects of phenytoin and fosphenytoin in children with severe malaria and status epilepticus.Br J Clin Pharmacol. 2003 Jul;56(1):112-9. doi: 10.1046/j.1365-2125.2003.01829.x. Br J Clin Pharmacol. 2003. PMID: 12848783 Free PMC article.
-
Phenytoin pharmacokinetics and clinical effects in African children following fosphenytoin and chloramphenicol coadministration.Br J Clin Pharmacol. 2002 Dec;54(6):635-42. doi: 10.1046/j.1365-2125.2002.01689.x. Br J Clin Pharmacol. 2002. PMID: 12492612 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources